Primary Peritoneal High Grade Serous Adenocarcinoma

general

A serous adenocarcinoma that arises from the lining of the peritoneum. It is characterized by high-grade histopathologic features.

79

Centers

276

Active Trials

Cancer Funding

Specific Cancer Types(3)

Top Centers for Primary Peritoneal High Grade Serous Adenocarcinoma(79)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
72.8
272.0
3
NCI Comprehensive
High-Volume Research Center
72.0
4
High-Volume Research Center
70.6
5
High-Volume Research Center
70.6
6
High-Volume Research Center
70.6
7
NCI Comprehensive
Active Research Program
66.9
8
NCI Comprehensive
Active Research Program
66.9
9
NCI Comprehensive
Active Research Program
66.9
10
NCI Comprehensive
Active Research Program
66.9
11
NCI Comprehensive
Active Research Program
66.9
12
NCI Comprehensive
Active Research Program
66.9
13
NCI Comprehensive
Active Research Program
66.9
14
NCI Comprehensive
Active Research Program
66.9
15
Active Research Program
66.9
16
Active Research Program
66.9
17
NCI Comprehensive
Active Research Program
57.8
18
NCI Comprehensive
Active Research Program
57.8
19
NCI Comprehensive
Active Research Program
57.8
20
NCI Comprehensive
Active Research Program
57.8
21
NCI Comprehensive
Active Research Program
57.8
22
NCI Comprehensive
Active Research Program
57.8
23
NCI Comprehensive
Active Research Program
57.8
24
NCI Comprehensive
Active Research Program
57.8
25
NCI Comprehensive
Active Research Program
57.8
26
NCI Comprehensive
Active Research Program
57.8
27
NCI Comprehensive
Active Research Program
57.8
28
NCI Clinical
Active Research Program
57.8
29
NCI Comprehensive
Active Research Program
57.8
30
NCI Clinical
Active Research Program
57.8
31
NCI Comprehensive
Active Research Program
57.8
32
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
57.8
33
NCI Clinical
Active Research Program
57.8
34
Active Research Program
57.8
3557.8
36
Active Research Program
57.8
37
Active Research Program
57.8
38
Active Research Program
57.8
39
NCI Comprehensive
Active Research Program
45.8
40
NCI Comprehensive
Active Research Program
45.8
41
NCI Comprehensive
Active Research Program
45.8
42
NCI Comprehensive
Active Research Program
45.8
43
NCI Comprehensive
Active Research Program
45.8
44
NCI Comprehensive
Active Research Program
45.8
45
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
45.8
46
NCI Comprehensive
Active Research Program
45.8
47
NCI Comprehensive
Active Research Program
45.8
48
NCI Clinical
Active Research Program
45.8
49
NCI Comprehensive
Active Research Program
45.8
50
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
45.8
51
NCI Comprehensive
Active Research Program
45.8
52
NCI Comprehensive
Active Research Program
45.8
53
NCI Comprehensive
Active Research Program
45.8
54
NCI Basic_laboratory
Active Research Program
45.8
5545.8
56
Active Research Program
45.8
57
Active Research Program
45.8
58
Active Research Program
45.8
59
NCI Comprehensive
Contributing Research Center
34.4
60
NCI Comprehensive
Contributing Research Center
34.4
61
NCI Comprehensive
Contributing Research Center
34.4
62
NCI Comprehensive
Contributing Research Center
34.4
63
NCI Comprehensive
Contributing Research Center
34.4
64
NCI Comprehensive
Contributing Research Center
34.4
65
NCI Comprehensive
Contributing Research Center
34.4
66
Contributing Research Center
34.4
67
NCI Clinical
Contributing Research Center
34.4
68
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Contributing Research Center
34.4
69
Contributing Research Center
34.4
70
Contributing Research Center
34.4
71
Contributing Research Center
34.4
72
Contributing Research Center
34.4
73
Contributing Research Center
34.4
74
Contributing Research Center
34.4
75
Contributing Research Center
34.4
76
Contributing Research Center
34.4
77
Contributing Research Center
34.4
78
Contributing Research Center
34.4
79
NCI Comprehensive
28.4

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →